Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Azienda USL Toscana Centro

Research site

Italy Via Ciliegiole 97, 51100 Pistoia, Italy

  • 2 trials recruiting
  • Acute coronary syndrome · Adenocarcinoma pancreas · Atrial fibrillation
  • Adults and children

About Specializations

Azienda USL Toscana Centro in Pistoia, Italy specialises in clinical trials of conditions such as Acute coronary syndrome, Adenocarcinoma pancreas, Atrial fibrillation, Cardiovascular disorder, and other specialisations. This site conducts important research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Via Ciliegiole 9751100 PistoiaItaly
Open in maps ↗
Recruiting now
2 trials
Conditions studied
19

More sites in PistoiaItaly

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Cardiovascular disorder

Recruiting

Study on Colchicine and Aspirin for Improving Heart Health in Adults with Type 2 Diabetes Without Previous Heart Events

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carbasalate Calcium
  • Sponsor:Montreal Heart Institute

Atrial fibrillation+2

Recruiting

Study on Edoxaban for Patients with Atrial Fibrillation and Coronary Syndrome Undergoing PCI

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:St Antonius Hospital

Testing Personalized Antibiotic Treatment with Amoxicillin and Clavulanic Acid for Children with Febrile Urinary Tract Infections

Not yet recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Amoxicillin
  • Sponsor:Istituto Di Ricovero E Cura A Carattere Scientifico Materno Infantile Burlo Garofolo

Colorectal cancer metastatic+14

Not recruiting

Study of Tisotumab Vedotin, Pembrolizumab, and Platinum Drug Combination for Patients with Advanced or Metastatic Solid Tumors

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Seagen Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.